Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
<jats:title>Abstract</jats:title><jats:p>Transfer of convalescent plasma (CP) had been proposed early during the SARS-CoV-2 pandemic as an accessible therapy, yet trial results worldwide have been mixed, potentially due to the heterogeneous nature of CP. Here we perform deep profil...
Main Authors: | Herman, Jonathan D, Wang, Chuangqi, Loos, Carolin, Yoon, Hyunah, Rivera, Johanna, Eugenia Dieterle, M, Haslwanter, Denise, Jangra, Rohit K, Bortz, Robert H, Bar, Katharine J, Julg, Boris, Chandran, Kartik, Lauffenburger, Douglas, Pirofski, Liise-anne, Alter, Galit |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC
2023
|
Online Access: | https://hdl.handle.net/1721.1/147864 |
Similar Items
-
Nucleocapsid-specific antibody function is associated with therapeutic benefit from Covid-19 Convalescent plasma therapy
by: Herman, Jonathan D, et al.
Published: (2023) -
Dissecting the antibody-OME: past, present, and future
by: Loos, Carolin, et al.
Published: (2021) -
Dissecting the antibody-OME: past, present, and future
by: Loos, Carolin, et al.
Published: (2021) -
Discrete SARS-CoV-2 antibody titers track with functional humoral stability
by: Bartsch, Yannic C., et al.
Published: (2021) -
Neutralizing antibodies in convalescent patients
by: Uhl, LFK, et al.
Published: (2020)